TriTAC® Technology
Watch our TriTAC technology unleash the target cell-killing properties of a patient’s own immune system.
Science
Harpoon has created a novel antibody-based drug discovery platform called TriTAC®, which offers a new way to unleash the target cell-killing properties of a patient’s own immune system.
Careers
Harpoon is seeking energetic, passionate scientists and innovators to join our effort.
Recent News
January 8,
2024
Merck to Acquire Harpoon Therapeutics, Further Diversifying Oncology Pipeline
December 26,
2023
Harpoon Therapeutics Strengthens Leadership Team